As part of our strategy going forward we are aggressively...
As part of our strategy going forward we are aggressively looking at alliances and joint ventures and acquisitions of biotech companies.
As part of our strategy going forward we are aggressively looking at alliances and joint ventures and acquisitions of biotech companies.